Lantern Pharma Inc. Equity Securities, FV-NI, Realized Loss
Lantern Pharma Inc. (LTRN) reported Equity Securities, FV-NI, Realized Loss of $38.96 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Income Statement › Other Income
us-gaap:EquitySecuritiesFvNiRealizedLoss · last filed 2026-08-14
- Lantern Pharma Inc. equity securities, fv-ni, realized loss for the quarter ending 2025-12-31 was $49.99K.
- Lantern Pharma Inc. equity securities, fv-ni, realized loss for the quarter ending 2025-09-30 was $72.68K.
- Lantern Pharma Inc. equity securities, fv-ni, realized loss for the quarter ending 2025-06-30 was $0.00.
- Lantern Pharma Inc. equity securities, fv-ni, realized loss for the quarter ending 2025-03-31 was $142.25K.
- Lantern Pharma Inc. equity securities, fv-ni, realized loss for fiscal 2025 was $264.91K.
| Period end | Equity Securities, FV-NI, Realized Loss 3 month | Equity Securities, FV-NI, Realized Loss 6 month | Equity Securities, FV-NI, Realized Loss 9 month | Equity Securities, FV-NI, Realized Loss 12 month |
|---|---|---|---|---|
| 2026-06-30 | $38.96K 10-Q · filed 2026-08-14 | |||
| 2025-12-31 | $49.99K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | $122.67K derived: sum of 2 quarters · filed 2026-03-30 | $122.67K derived: sum of 3 quarters · filed 2026-08-14 | $264.91K 10-K · filed 2026-03-30 |
| 2025-09-30 | $72.68K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $72.68K derived: sum of 2 quarters · filed 2026-08-14 | $214.93K 10-Q · filed 2025-11-12 | |
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | $142.25K 10-Q · filed 2026-08-14 | ||
| 2025-03-31 | $142.25K 10-Q · filed 2026-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |